VOYA INVESTMENT MANAGEMENT LLC - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 217 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
VOYA INVESTMENT MANAGEMENT LLC ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,835,230
-38.9%
179,949
-18.9%
0.01%
-40.0%
Q2 2023$7,915,486
+35.2%
221,971
-3.7%
0.01%
+25.0%
Q1 2023$5,854,904
-43.8%
230,508
-10.3%
0.01%
-46.7%
Q4 2022$10,420,392
+25.0%
256,913
+1.8%
0.02%
+25.0%
Q3 2022$8,337,127
+3.8%
252,258
+10.6%
0.01%
-40.0%
Q2 2022$8,032,000
+16.3%
228,111
+51.9%
0.02%
+42.9%
Q1 2022$6,905,000
-2.1%
150,132
+41.2%
0.01%0.0%
Q4 2021$7,051,000
-57.9%
106,349
-60.4%
0.01%
-58.8%
Q3 2021$16,750,000
-24.6%
268,313
+0.0%
0.03%
-20.9%
Q2 2021$22,213,000
+19.4%
268,215
-4.4%
0.04%
+13.2%
Q1 2021$18,604,000
-18.0%
280,580
-5.1%
0.04%
-17.4%
Q4 2020$22,693,000
+46.2%
295,747
-18.0%
0.05%
+35.3%
Q3 2020$15,522,000
-3.3%
360,459
-3.0%
0.03%
-8.1%
Q2 2020$16,049,000
+18.0%
371,611
-21.4%
0.04%0.0%
Q1 2020$13,606,000
-50.5%
472,933
+9.1%
0.04%
-35.1%
Q4 2019$27,504,000
+1513.1%
433,617
+616.8%
0.06%
+1325.0%
Q3 2019$1,705,000
+6.0%
60,493
-0.3%
0.00%
+33.3%
Q2 2019$1,608,000
+135.4%
60,681
+63.1%
0.00%
+50.0%
Q1 2019$683,000
+52.1%
37,212
+2.9%
0.00%
+100.0%
Q4 2018$449,000
-31.1%
36,149
+6.3%
0.00%0.0%
Q3 2018$652,000
+41.1%
33,9980.0%0.00%0.0%
Q2 2018$462,000
+842.9%
33,998
+28.8%
0.00%
Q1 2017$49,000
+19.5%
26,3920.0%0.00%
Q4 2016$41,000
-78.9%
26,3920.0%0.00%
Q3 2016$194,000
+38.6%
26,3920.0%0.00%
Q2 2016$140,00026,3920.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 908,474$24,410,69622.12%
Western Financial Corp/CA 820,239$22,039,82216.16%
JOHNSON & JOHNSON 247,598$6,652,9582.45%
WEALTH EFFECTS LLC 164,750$4,426,8352.19%
M28 Capital Management LP 67,400$1,811,0382.08%
Privium Fund Management B.V. 259,036$6,960,2982.07%
Evolutionary Tree Capital Management, LLC 51,266$1,377,5171.78%
Avidity Partners Management LP 1,063,897$28,586,9121.15%
SECTORAL ASSET MANAGEMENT INC 157,552$4,233,4220.82%
Vivo Capital, LLC 137,411$3,692,2340.40%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders